Sec. 2. Regulation of human cadaveric islet transplants
237 words·~1 min read·
/bill/119/s/3105/is/section-2A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Section 374(d)(2) of the Public Health Service Act ( 42 U.S.C. 274b(d)(2) ) is amended by striking pancreas, and inserting and pancreas, human cadaveric islets, . Notwithstanding any other provision of law, none of the following terms includes human cadaveric islets: The term drug , as defined in section 201(g) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321(g) ). The term biological product , as defined in section 351(i) of the Public Health Service Act ( 42 U.S.C. 262(i) ).
The term human cells, tissues, or cellular or tissue-based products (HCT/Ps) , as defined in section 1271.3 of title 21, Code of Federal Regulations (or any successor regulations). Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services (referred to in this section as the Secretary ) shall update regulations promulgated under parts F, G, and H of title III of the Public Health Service Act ( 42 U.S.C. 262 et seq. , 264 et seq., 273 et seq.) and the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 301 et seq. ), and such other regulations as the Secretary determines appropriate, to carry out the amendment made by subsection (a).
Not later than 6 months after the date of enactment of this Act, the Secretary shall report to Congress on the progress made in updating regulations as required under paragraph (1).
Connectionstraces to 4
Citation graph
cites case law
Cites 4Cited by 0 across 0 sources